Nick Keher is the Chief Financial Officer at Oxford Nanopore Technologies, where he oversees the Group’s finance function and investor relations. He brings significant experience in financial leadership within complex scientific businesses, contributing to the company's strategic financial planning and market positioning.

Before joining Oxford Nanopore, Nick served as CFO at both Clinigen Group and Benevolent AI, both listed businesses in the pharmaceutical and biotechnology sectors. His earlier career includes a role as Managing Director and Head of the European healthcare equity research team at Royal Bank of Canada (RBC). Prior to RBC, Nick held positions at Investec and GSK, following a transition from practising pharmacy to finance.

Nick’s academic background includes qualifications in pharmacy, which laid the foundation for his deep understanding of the life sciences sector. His extensive experience in capital markets and financial management equips him with the tools to navigate the complexities of the industry, ensuring robust financial health and investor confidence for Oxford Nanopore.